Stevioside, a constituent of Stevia rebaudiana, is commonly used as a non-caloric sugar substitute in Japan. The genetic toxicities of stevioside and its aglycone, steviol, were examined with seven mutagenicity tests using bacteria (reverse mutation assay, forward mutation assay, umu test and rec assay), cultured mammalian cells (chromosomal aberration test and gene mutation assay) and mice (micronucleus test). Stevioside was not mutagenic in any of the assays examined. The aglycone, steviol, however, produced dose-related positive responses in some mutagenicity tests, i.e. the forward mutation assay using Salmonella typhimurium TM677, the chromosomal aberration test using Chinese hamster lung fibroblast cell line (CHL) and the gene mutation assay using CHL. Metabolic activation systems containing 9000 g supernatant fraction (S9) of liver homogenates prepared from polychlorinated biphenyl or phenobarbital plus 5,6-benzoflavone-pretreated rats were required for mutagenesis and clastogenesis. Steviol was weakly positive in the umu test using S.typhimurium TA1535/pSK1002 either with or without the metabolic activation system. Steviol, even in the presence of the S9 activation system, was negative in other assays, i.e. the reverse mutation assays using S.typhimurium TA97, TA98, TA100, TA102, TA104, TA1535, TA1537 and Escherichia coli WP2 uvrA/pKMlOl and the rec-assay using Bacillus subtilis. Steviol was negative in the mouse micronucleus test The genotoxic risk of steviol to humans is discussed.
Introduction
Stevioside is a major sweet constituent of the herb, Stevia rebaudiana Bertoni, and has been widely used in Japan and Brazil as a non-nutritive sweetening agent (Melis, 1992) . The substance has been subjected to various assessments for safety and no serious toxic effects have been reported (Planas, 1968; Akashi and Yokoyama, 1975; Mori et ai, 1981; Medon et ai, 1982; Hagiwara et ai, 1984; Yamada et al., 1985; Aze et ai, © L'K Environmental Mutagen Society/Oxford University Press 1996 1991). Stevioside and crude extracts of S.rebaudiana have been determined to be non-mutagenic when tested against some tester strains of Salmonella typhimurium, Escherichia coli and Bacillus subtilis (Okumura et ai, 1978; Fujita et ai, 1979; Kawachi et ai, 1980) . It is known, however, that stevioside is converted to its aglycone steviol by intestinal bacteria when stevioside is orally administered to rats (Wingard et al, 1980; Nakayama et ai, 1986) . Pezzuto et ai (1985) examined the mutagenicity of stevioside and its related compounds and found that steviol showed a dose-related positive response in the forward mutation assay using S.typhimurium TM677. Steviol requires metabolic activation for mutagenesis and this reaction seems to be cytochrome P-450-dependent (Pezzuto et ai, 1986) . To further assess the genotoxicity of stevioside and steviol, we examined their possible mutagenicity, using six in vitro and one in vivo mutation assays. The results indicated that stevioside is not mutagenic in any of the assays examined but steviol with metabolic activation is mutagenic in the forward mutation assay using S.typhimurium TM677, the chromosome aberration test and the gene mutation assay using Chinese hamster lung fibroblast cell line (CHL).
Materials and methods

Chemicals
Stevioside (CAS registry number 57817-89-7) and steviol (CAS registry number 471-80-7) were kindly provided by Maruzenn Kasei Ltd, Japan. Stevioside was isolated from the crude extracts of S. rebaudiana and steviol was enzymatically prepared from stevioside. The purities of stevioside and steviol were 83.2 and 99.0% respectively, as determined by high performance liquid chromatographic analysis [for stevioside analysis: Lichrosorb NH 2 column, acetonitrile:water (4:1), for steviol analysis: Nucleosil 5 C| 8 column, acetonitrile:water (4:1)]. Stevioside and steviol were dissolved in dimethylsulphoxide (DMSO) when used for the mutagenicity tests, unless otherwise indicated. NADP + , NADPH, glucose-6-phosphate (G-6-P), G-6-P dehydrogenase and NADH were purchased from Oriental Yeast Co. Ltd (Tokyo, Japan).
Metabolic activation system
The liver 9000 g supernatant fraction (S9) was prepared from Fischer rats (Charles River Japan Co., Chiba, Japan) pretreated with polychlorinated biphenyls (Kanechlor KC-400, 500 mg/kg) 5 days before sacrifice. This S9 was used for all the mutagenicity tests except for umu test and the gene mutation assay using CHL cells, in which S9 prepared from Sprague-Dawley rats pretreated with phenobarbital plus 5,6-benzoflavone was used. The latter S9 was purchased from Oriental Yeast Co.
Salmonella/micwsome mutagenicity test
The mutagenicity test was carried out according to the method of Maron and Ames (1983) combined with a pre-incubation procedure for 20 min at 37°C. All the S.typhimurium tester strains used were provided by Dr B.N.Ames, University of California, Berkeley, CA, USA. Duplicate plates were used for each of five different test substance concentrations.
Fnn\ ard mutation assay
The assay was carried out with modifications according to the method described by Skopek et al. (1978a,b) . Briefly, the test sample (50 u.1), a logphase culture of tester strain (800 (jl), S9 (100 ul) and cofactor solution flCO ]i\) made up with G-6-P (5 mg), G-6-P dehydrogenase (2 V), N'ADPH (5 mg) and MgCl 2 (3.3 mg) in minimal medium E (0.5 ml) were added to a small ttst tube. For the experiments without activation, the test sample (50 uij was mixed with the log-phase culture (1 ml) alone. After incubation at 37°C for 1 h with shaking (100 r.p.m.), the suspension was centrifuged at 2000 g for 15 min and the pellet was resuspended in phosphate-buffered saline (pH 7.0). To determine the number of 8-azaguanine (8-AG) resistant cells, -1X10 5 cells were spread on agar plates containing 8-AG (50 ug/ml) To determine toxicity, a diluted suspension was plated on the same plates without 8-AG. After incubation at 37°C for 2 days, the numbers of colonies arising on the mutation and toxicity plates were counted. The mutation frequency was calculated as MXD/S where M is the average number of colonies (mutants) on 8-AG-containing plates, S is the average number of colonies (viables) on plates without 8-AG and D is the dilution factor. The tester strains, S.typhimunum TM677 and TM35, were provided by Dr W.G.Thilly, Massachusetts Institute of Technology, Cambridge, MA, USA Salmonella typhimunum KH75 was constructed by introducing the plasmid pKMlOl into a spontaneous His" 1 " revertant of S.typhimunum TA1975. These strains were cultured overnight using Brain Heart Infusion media and stored at -80°C until use.
umu test
The umu test was performed according to the method of Oda et al. (1985) with slight modifications. Briefly, the incubation mixture consisted of the test compound dissolved in DMSO (10 |il), a log-phase culture of tester strain S.typhimurium TA1535/pSKI002 (240 \x\) and either 0.1 M phosphate buffer pH 7.4 (50 nl) or S9 mix (50 ul) containing 5 ul of S9 fraction. The composition of S9 mix was described previously (Oda et al, 1985) After incubation for 2 h at 37°C, each mixture was diluted 10 times with TGA medium and further incubated for 3 h at 37°C. After incubation, the cell density (ODgon) of each culture was measured and P-galactosidase activity was assayed by the method of Miller (1972) . The genotoxic activities of the test substances were defined as specific (J-galactosidase activities, and the data are presented as mean values of duplicate or triplicate determinations.
Spore rec-assay
The assay was earned out according to the method of Hirano et al. (1982) . A paper disk (8 mm in diameter) was placed on the centre of agar plates containing spores of B.subtilis either with or without S9. A DMSO solution of the test substance (40 jxJ) and either buffer solution (20 JJJ) or cofactor solution (20 |il) were placed on the paper disk. The buffer solution contained 8 uM MgCl 2 and 33 uM KC1 in 10 mM phosphate buffer pH 7.2. The cofactor solution contained G-6-P and NADP + (40 and 80 mg/ml of the buffer solution respectively). After incubation at 4°C overnight, the plates were incubated again overnight at 37°C and the diameter of the inhibition zones was measured. Bacillus subtilis H17 Rec + and M45 Rec" were provided by the late Dr T.Kada, Department of Induced Mutation, National Institute of Genetics, Mishima, Japan.
Chromosomal aberration test in vitro
A CHL cell line was used (Ishidate and Odashima, 1977) . The cells were treated for 24 and 48 h with a test compound at three or more dose levels Stevioside and steviol were dissolved in physiological saline and DMSO respectively. The maximum dose of each test compound was selected from the doses at which >50% cell growth inhibition was observed in a preliminary test. For the metabolic activation, the cells were treated with the S9 mix together with the test compound (Matsuoka et al., 1979) . After treatment for 6 h, the reaction, mixture was replaced with fresh medium, and then the cells were recultured for 18 h. Both with and without the metabolic activation system, the cells were treated with colcemid (0.2 mg/ml) for 2 h, and chromosome preparations were made using a standard air-dry method. The frequency of the cells with chromosomal aberrations was scored in 100 wellspread metaphases for each dose. Types of structural chromosomal aberrations were classified into five groups: chromatid gaps (ctg) including chromosome gaps (csg), chromatid breaks (ctb), chromatid exchanges (cte), chromosome breaks (csb) and chromosome exchanges (cse) including dicenlnc and ring chromosomes Polyploid cells were also recorded. The final result of the test compound was judged as follows: negative (-) if the frequency of aberrant cells was <5%, inconclusive (±) if »=5% but < 10%, and positive ( + ) if 3= 10*
Gene mutation assay with cultured mammalian cells
The assay was performed according to the method of Nakayasu et al. (1982) . CHL cells in logarithmic phase of growth were exposed to steviol dissolved in DMSO for 3 h at 37°C in the presence of S9 mix (1 ml), which contained 4.27 mM G-6-P, 0.75 mM NADP + and 5% S9 in Eagle's minimum essential medium supplemented with double concentrations of vitamins and amino acids. After the treatment, the cells were washed and collected after trypsinization. For determination of cytotoxicity, the treated cells (200-400 cells) were cultured for 7 days and the numbers of surviving colonies were counted. For determination of mutation frequency, the remaining portion of the cells was cultured in fresh medium for 7 days. After the expression time, an aliquot (2.5 X10 5 cells) was transferred to fresh medium containing diphtheria toxin (0.1 Lf/ml), cultured for another 7 days and the number of diphtheria toxin resistant (DT r ) colonies was scored. Another aliquot of the cell suspension (250 cells) was transferred to toxin-free medium to determine the plating efficiency. The mutation frequency was expressed as the number of DT' cells per 2.5X1O 5 survivors, normalized by the plating efficiency.
Micronucleus test
The in vivo micronucleus test on steviol was earned out using MS/Ae mice (Aeschbacher et al, 1979; Hayashi et al, 1982) . Male MS/Ae mice (aged 7 weeks) were purchased from the Hitachi Medical Animals Laboratories (Sanwa, Japan), and were used for the experiments after 2 weeks of acclimation (body weight: 32 8-36.2 g). Mice were given commercial pellets (CE2; Japan Clea) and water ad libitum throughout the acclimation and expenments. In each dose group, six mice were used. The test compound suspended in olive oil was administered once by i.p. injection at four dose levels (125, 250, 500 and 1000 mg/kg) Mitomycin C (2.0 mg/kg) was used for the positive control and olive oil for the negative control. All mice were killed by cervical dislocation 24 h after treatment, except that an additional six mice that were injected once with 500 mg/kg of the test compound were killed 48 h after treatment. Femoral marrow cells were flushed out with fetal bovine serum and smeared on clean glass slides Cells were fixed with methanol for 5 min, and stained with 3% Giemsa. The preparations were coded and analysed without any knowledge of the treatment One thousand polychromatic and normochromatic erythrocytes per mouse were scored, and the numbers of micronucleated polychromatic erythrocytes (MNPCEs) and of micronucleated normochromatic erythrocytes (MNNCEs) were recorded. The numbers of micronucleated erythrocytes (MNEs) and the proportion of polychromatic erythrocytes (PCEs) relative to the total erythrocytes were evaluated by observing 1000 erythrocytes on the same slide The results obtained from each dose level were analysed statistically according to the table presented by Kastenbaum and Bowman (1970) 
Results
Reverse mutation assays using S.typhimurium and E.coli
Stevioside and steviol were not mutagenic toward S.typhimurium TA97, TA98, TA100, TA102 and TA104 either with or without S9 mix at doses up to 5 mg per plate (Table I) . They were not toxic to S.typhimurium even at the highest dose. Neither stevioside nor steviol was mutagenic in S.typhimurium TA1535, TA1537 and E.coli WP2 wvM/pKM101 "in the presence of S9 mix (data not shown). These results suggest that neither stevioside nor steviol is mutagenic in S.typhimurium TA strains and E.coli WP2 wvM/pKMlOl either with or without metabolic activation.
Forward mutation assay using S.typhimurium TM677
Stevioside induced no significant increase of the mutation frequency of S.typhimurium TM677, even at the highest dose of 10 mg/ml, either with or without S9 mix (data not shown). However, steviol induced a significant dose-related increase in the mutation frequency when S9 mix was present (Table  II) . Steviol increased not only the mutation frequency but also the raw number of 8-AZ resistant colonies (mutants) per plate, ruling out the possibility that the mutagenicity of steviol was an artefact due to the analysis of the data (Procinska et al., 1991) . In the absence of S9 mix, steviol did not give rise to an increase in the mutation frequency. To determine the genetic requirements for the mutagenicity of steviol, we compared the sensitivities of three isogenic tester strains in the presence of S9 mix (Figure 1 ). Of the three strains examined, S.typhimurium TM677 (uvrB, rfa, pKMlOl) exhibited much higher sensitivity toward steviol than did S.typhimurium TM35 (uvrB, rfa) or KH75 (rfa, pKMlOl). These results suggest that steviol is mutagenic to S.typhimurium TM677 in the presence of S9 mix and also that rfa mutation, deficiency of excision repair and presence of plasmid pKMlOl are all required for the maximum mutagenesis. umu test Stevioside induced no significant increase in the specific p-galactosidase activity of S.typhimurium TA1535/pSK1002
Evaluation of the genotoxicity of stevioside and stcviol 'After incubation for 1 h at 37°C, reaction mixtures were centrifuged and cell pellets resuspended in 1 ml phosphate-buffered saline. After dilution by 10 3 , 0.1 ml of the diluted cell suspension was spread on agar plates, followed by incubation at 37°C for 2 days. Duplicate plates were used for determining the numbers of survivors and the mean values are indicated. either with or without S9 mix (Table III) . However, steviol induced an increase (~2-fold) in the specific activity of f3-galactosidase at concentrations of 625-1250 |ig/ml in the absence of S9 mix and 1250-2500 ng/ml in the presence of S9 mix. Under the conditions used, positive control chemicals, i.e. furylfuramide (0.03 (ig/mJ without activation) and 2-aminoanthracene (3.3 |ig/ml with activation) substantially increased the specific activity of P-galactosidase of S.typhimurium TA1535/pSK1002. These results suggest that steviol is weakly positive in the umu test either with or without metabolic activation.
rec-assay
Neither stevioside nor steviol, either with or without S9 activation, inhibited the growth of B.subtilis H17 Rec + and M45 Rec (data not shown). The highest doses were 10 mg per paper disk. We also examined the genotoxicities of stevioside and steviol using the 'streak' rec-assay (Kada et al., 1972) . The two chemicals did not show any DNA damaging activities to B.subtilis either with or without S9 activation up to the concentration of 10 mg per paper disk (data not shown). Positive control chemicals, i.e. furylfuramide (0.01 (ig without S9 activation) and 2-aminoanthracene (10 ng with S9 activation), inhibited the growth of B.subtilis M45 Rec" to a greater extent than that of H17 Rec + in both spore and streak recassays. These results suggest that both stevioside and steviol are negative in the spore and streak rec-assays.
Chromosomal aberration test in vitro
In 24 and 48 h treatments without S9 mix, stevioside caused no significant increase in the frequencies of cells with chromosomal aberrations at doses up to 8.0 mg/ml. Cytotoxicity of the CHL cells was observed at 12.0 mg/ml both in 24 and 48 h treatments (Table IV) . With S9 mix, it was negative at doses up to 12.0 mg/ml. Steviol was also negative at doses up to 0.5 mg/ml at 24 and 48 h treatments, without S9 mix (Table V) . With S9 mix, on the other hand, steviol induced chromosomal aberrations at the dose range of 1.0-1.5 mg/ml (13-45% of aberrant cells). The majority of the aberrations were chromatid exchanges. The results indicate that steviol is clastogenic to cultured Chinese hamster cells only after metabolic activation.
Gene mutation assay of cultured mammalian cells
Treatment of CHL cells with steviol for 3 h in the presence of S9 mix induced a substantial dose-dependent increase in the number of mutants that were resistant to diphtheria toxin (Table VI) . At the highest dose of 400 (ig/ml, the frequency of DT r mutants per survivors was about three times higher than that of the control. The mutagenicity of steviol on CHL cells in the presence of S9 mix is consistent with the results of preliminary experiments, in which steviol exhibited a dosedependent increase in mutation frequency. The frequency was 110 DT r -mutants per 2.5 X10 5 survivors at a dose of 400 |ig/ ml. These results suggest that steviol is mutagenic to CHL cells in the presence of S9 mix. The mutagenicity of steviol without metabolic activation was not studied.
Micronucleus test
Steviol did not induce significant increases in the frequencies of MNPCEs, MNNCEs or MNEs at each treatment group (Table VII) . No apparent changes were observed in the proportion of PCEs to total erythrocytes. At the highest dose of 1000 mg/kg, four out of six mice died, indicating that dose levels over the present maximum dose were unavailable for the micronucleus tests. Mitomycin C (2.0 mg/kg), a positive control, induced a significant increase in frequencies of MNPCEs and MNEs. These results suggest that steviol does not induce micronuclei in bone marrow erythrocytes of mice.
Discussion
To evaluate the genotoxic activities of stevioside and its aglycone. steviol, we carried out six in vitro and one in vivo mutagenicity assays. The results suggested that stevioside has no mutagenic or clastogenic potential in bacteria or cultured mammalian cells either with or without S9 activation (Table  VIII) . This is consistent with the previous reports that stevioside is negative with or without metabolic activation in mutagenicity tests using bacteria, cultured mammalian cells or insects ctg, chromatid gaps (including chromosome gaps); ctb, chromatid breaks; cte, chromatid exchanges; frg, fragmentation; csb, chromosome breaks; cse, chromosome exchanges; CMC, carboxymethylcellulose; DMSO, dimethyl sulphoxide. (Okumura et ai, 1978; Medon et ai, 1982; Kawachi et ai, 1980; Kerr et ai, 1983; Pezzuto et ai, 1985; Nadamitsu et ai, 1985) . It has also been reported that structurally related species, such as steviobioside, dulcoside A, rebaudioside A, rebaudioside B, rebaudioside C, isosteviol, dihydrosteviol A and dihydrosteviol B, are all negative in the forward mutation assay using S.typhimurium TM677 in the presence of S9 activation (Pezzuto et ai, 1985) . In contrast, the aglycone, steviol, was positive in the forward mutation assay using S.typhimurium TM677, the umu test using S.typhimurium TA1535/pSK10O2, the chromosomal aberration test and the gene mutation assay using CHL cells when S9 mix was present (Table VIII) . The mutagenicity of steviol in the forward mutation assay is reported by Pezzuto et al. (1985) . In the absence of S9 activation, the results of steviol were negative except for the umu test, in which it weakly increased the specific activity of P-galactosidase (Table III) . Thus, we suggested that some metabolite(s) of steviol generated by S9 enzymes has genotoxic activities in bacteria and cultured mammalian cells. "Cytotoxicity was determined by cultunng steviol-treated cells (200-400 cells) for 7 days and counting the numbers of surviving colonies. 'The number of diphtheria toxin-resistant colonies were determined by cultunng the treated cells (2.5X 10 5 cells) in medium containing diphtheria toxin for 7 days and counting the number of surviving colonies Tlating efficiency was determined by cultunng the treated cells (250 cells) in toxin-free medium for 7 days and counting the surviving colonies. *rhe number of diphtheria toxin-resistant colonies per 2X1O 5 survivors was calculated by dividing the number of diphtheria toxin resistant colonies per dish by 1/100 of the percent of plating efficiency e N, yV-dimethylnitrosamine; DT, Diptheria toxin. The primary metabolic pathways of steviol catalyzed by S9 enzymes involve allylic oxidation and epoxidation (Compadre et al., 1988) . The possibility that the active metabolite is an epoxide is ruled out because epoxide hydrolase does not inhibit steviol-induced mutagenicity (Pezzuto et al., 1986) . Compadre etal. (1988) proposed that 15-oxosteviol, an oxidative metabolite of 15-hydroxysteviol, is the active metabolite, since it induces mutations that confer 8-azaguanine resistance in S.typhimurium TM677 without further metabolic activation. However, Procinska et al. (1991) could not confirm the directacting mutagenicity of 15-oxosteviol and suggested that the conclusion by Compadre et al. was due to misinterpretation of the data. Thus, at this moment, the active metabolite(s) of steviol that causes mutations in S.typhimurium TM677 remains to be identified. Procinska et al. (1991) also suggested that the observed mutagenicity with steviol might be due to an impurity, because the mutagenicities of the steviol solution increase as the amount added to the solution increases up to 10 mg/ml, whereas the concentration of steviol is limited to its saturation level of ~1 mg/ml. Although we can not rule out the possibility, we do not think it is likely, because we have confirmed the positive results of Pezzto et al. (1986) with different preparations of steviol. Also, secondly some substances, such as polycyclic hydrocarbons, that are very insoluble in aqueous media still exhibit increasing genotoxic responses with dose above the solubility limit (KirkJand, 1994) . Although steviol was mutagenic and clastogenic in bacteria and cultured mammalian cells, it did not exhibit any positive response in the mouse micronucleus test (Table VII) . This in vivo test result does not necessarily mean that neither mutagenic nor clastogenic metabolites are generated from steviol in vivo. It could be possible that steviol produced adverse metabolites in vivo but they did not reach the bone marrow, the target organ for the micronucleus test. In fact, dimethylnitrosamine and diethylnitrosamine, potent hepatocarcinogens, do not give rise to a substantial increase in the number of micronucleated cells in mouse micronucleus test, probably because the short-lived active metabolites generated in the liver can not reach the bone marrow (Proudlock and Allen, 1986; Cliet et al., 1993) . It might also be possible that the genotoxic metabolites of steviol could reach bone marrow but that they predominantly induced point mutations, such as base change or frameshifts, rather than chromosome aberrations, so that no micronucleated blood cells were found in the steviol-treated mice. Thus, further work is necessary to predict the genotoxic risk of steviol to human beings. Since steviol requires S9 activation for mutagenesis and clastogenesis in vitro, the genotoxic damage in the liver of rats or mice should be examined. In this respect, the liver unscheduled DNA synthesis (UDS) assay or a transgenic mutagenicity assay would be appropriate for the further assessment of the genotoxic potential of steviol in vivo.
In summary, we examined the mutagenicity and clastogenicity of stevioside and its aglycone, steviol, with in vitro and in vivo mutagenicity tests. Although stevioside was negative in all of the assays examined, steviol gave rise to an increase in gpt gene mutations in S.typhimurium TM677, in chromosome aberrations and DT r gene mutations in CHL cells when S9 mix was present. Although the number of micronucleated cells in bone marrow erythrocytes did not increase in steviol-treated mice, the present in vitro test results suggested the necessity of other in vivo mutagenicity tests such as liver UDS assay or transgenic mouse mutagenicity test for more precise assessment of genotoxic risk of steviol to human beings.
